In endocrine irAEs, hormone replacement or disease-specific therapy was the mainstay: levothyroxine for hypothyroidism, insulin or oral hypoglycemics for diabetes, carbimazole for hyperthyroidism, and fluid restriction for hyponatremia or SIADH. Here, INS is linked to hyperthyroidism.